Peter Attia, MD опубликовал беседу с Allan Sniderman о Cardiovascular disease and why we should change the way we assess risk

Author: John Donne [262 views] 2021-11-29 11:00:57

Записки беседы, pdf

Allan Sniderman is a highly acclaimed Professor of Cardiology and Medicine at McGill University and a foremost expert in cardiovascular disease (CVD).

Allan explains the many risk factors used to predict atherosclerosis, including triglycerides, cholesterol, and lipoproteins, and he makes the case for apoB as a superior metric that is currently being underutilized.

Allan expresses his frustration with the current scientific climate and its emphasis on consensus and unanimity over encouraging multiple viewpoints, thus holding back the advancement of metrics like apoB for assessing CVD risk, treatment, and prevention strategies.


185 - Cardiovascular disease and why we should change the way we assess risk; 2:25:35 [1,807 views]

Reply
|
Reply to sender (private) |
Synchronize | Thread